ARMISTICE CAPITAL LLC 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:47 pm Sale | 2024-09-30 | 13G | Aquestive Therapeutics, Inc. AQST | ARMISTICE CAPITAL LLC | 2,750,000 2.930% | -1,174,000 (-29.92%) | Filing |
| 2024-02-14 3:24 pm Purchase | 2023-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | ARMISTICE CAPITAL LLC | 3,924,000 5.880% | 3,924,000 (New Position) | Filing |